Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli

European Journal of Immunology

Volumn 47, Issue 6, 2017, Pages 1009-1021

  Leiber, Anja ^a   Schwarz, Julian ^a   Köstlin, Natascha ^a   Spring, Bärbel ^a   Fehrenbach, Birgit ^a   Katava, Nenad ^a   Poets, Christian F ^a   Gille, Christian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Cord blood; E. coli; Infection; MDSC; Neonates; PMN

Indexed keywords

PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; CD11B ANTIGEN; CYTOKINE; NUCLEAR PROTEIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BACTERIUM CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INFECTION SENSITIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MYELOID-DERIVED SUPPRESSOR CELL; NEUTROPHIL; NEWBORN PERIOD; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; BIOSYNTHESIS; CYTOLOGY; FETUS BLOOD; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; NEWBORN; PHYSIOLOGY;

ANTIGENS, CD11B; APOPTOSIS; CARRIER PROTEINS; CYTOKINES; ESCHERICHIA COLI; FETAL BLOOD; HUMANS; IMMUNE TOLERANCE; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; MYELOID-DERIVED SUPPRESSOR CELLS; NEUTROPHILS; NUCLEAR PROTEINS; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 85019839102     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646621     Document Type: Article

References (34)

1. Levy, O., Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007. 7: 379–390.
2. Stoll, B. J., Hansen, N. I., Bell, E. F., Shankaran, S., Laptook, A. R., Walsh, M. C., Hale, E. C. et al., Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010. 126: 443–456.
3. Thomas, W. and Speer, C. P., Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology 2011. 99: 177–187.
4. Leviton, A., Fichorova, R., Yamamoto, Y., Allred, E. N., Dammann, O., Hecht, J., Kuban, K. et al., Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine 2011. 53: 66–73.
5. Hentschel, J., Berger, T. M., Tschopp, A., Muller, M., Adams, M., Bucher, H. U. and Swiss Neonatal, N., Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland. Eur. J. Pediatr. 2005. 164: 292–297.
6. Schlapbach, L. J., Aebischer, M., Adams, M., Natalucci, G., Bonhoeffer, J., Latzin, P., Nelle, M. et al., Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011. 128: e348–e357.
7. Strunk, T., Inder, T., Wang, X., Burgner, D., Mallard, C. and Levy, O., Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect. Dis. 2014. 14: 751–762.
8. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162–174.
9. Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R. and Ochoa, A. C., Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer. Res. 2009. 69: 1553–1560.
10. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S. and Bronte, V., Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010. 22: 238–244.
11. Rieber, N., Gille, C., Kostlin, N., Schafer, I., Spring, B., Ost, M., Spieles, H. et al., Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin. Exp. Immunol. 2013. 174: 45–52.
12. Youn, J. I., Collazo, M., Shalova, I. N., Biswas, S. K. and Gabrilovich, D. I., Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 2012. 91: 167–181.
13. DeLeo, F. R., Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004. 9: 399–413.
14. Hotchkiss, R. S. and Nicholson, D. W., Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 2006. 6: 813–822.
15. Zhang, B., Hirahashi, J., Cullere, X. and Mayadas, T. N., Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J. Biol. Chem. 2003. 278: 28443–28454.
16. Leiber, A., Graf, B., Spring, B., Rudner, J., Kostlin, N., Orlikowsky, T. W., Poets, C. F. et al., Neonatal monocytes express antiapoptotic pattern of Bcl-2 proteins and show diminished apoptosis upon infection with Escherichia coli. Pediatr. Res. 2014. 76: 142–149.
17. Rooswinkel, R. W., van de Kooij, B., Verheij, M. and Borst, J., Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell Death Dis 2012. 3: e366.
18. Knaul, J. K., Jorg, S., Oberbeck-Mueller, D., Heinemann, E., Scheuermann, L., Brinkmann, V., Mollenkopf, H. J. et al., Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am. J. Respir. Crit. Care. Med. 2014. 190: 1053–1066.
19. Pereira, W. F., Ribeiro-Gomes, F. L., Guillermo, L. V., Vellozo, N. S., Montalvao, F., Dosreis, G. A. and Lopes, M. F., Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses. J. Leukoc. Biol. 2011. 90: 1191–1197.
20. Poe, S. L., Arora, M., Oriss, T. B., Yarlagadda, M., Isse, K., Khare, A., Levy, D. E. et al., STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol 2013. 6: 189–199.
21. Chornoguz, O., Grmai, L., Sinha, P., Artemenko, K. A., Zubarev, R. A. and Ostrand-Rosenberg, S., Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis. Mol. Cell. Proteomics 2011. 10: M110 002980.
22. Condamine, T., Kumar, V., Ramachandran, I. R., Youn, J. I., Celis, E., Finnberg, N., El-Deiry, W. S. et al., ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J. Clin. Invest. 2014. 124: 2626–2639.
23. Hu, X., Bardhan, K., Paschall, A. V., Yang, D., Waller, J. L., Park, M. A., Nayak-Kapoor, A. et al., Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. J. Biol. Chem. 2013. 288: 19103–19115.
24. Ostrand-Rosenberg, S., Sinha, P., Chornoguz, O. and Ecker, C., Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). Cancer. Immunol. Immunother. 2012. 61: 1319–1325.
25. Gille, C., Leiber, A., Spring, B., Kempf, V. A., Loeffler, J., Poets, C. F. and Orlikowsky, T. W., Diminished phagocytosis-induced cell death (PICD) in neonatal monocytes upon infection with Escherichia coli. Pediatr. Res. 2008. 63: 33–38.
26. Solito, S., Marigo, I., Pinton, L., Damuzzo, V., Mandruzzato, S. and Bronte, V., Myeloid-derived suppressor cell heterogeneity in human cancers. Ann. N. Y. Acad. Sci. 2014. 1319: 47–65.
27. Autret, A. and Martin, S. J., Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol. Cell 2009. 36: 355–363.
28. Ray, A., Chakraborty, K. and Ray, P., Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front Cell Infect Microbiol 2013. 3: 52.
29. Janols, H., Bergenfelz, C., Allaoui, R., Larsson, A. M., Ryden, L., Bjornsson, S., Janciauskiene, S. et al., A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 2014. 96: 685–693.
30. Gervassi, A., Lejarcegui, N., Dross, S., Jacobson, A., Itaya, G., Kidzeru, E., Gantt, S. et al., Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses. PLoS One 2014. 9: e107816.
31. Gille, C., Spring, B., Tewes, L., Poets, C. F. and Orlikowsky, T., A new method to quantify phagocytosis and intracellular degradation using green fluorescent protein-labeled Escherichia coli: comparison of cord blood macrophages and peripheral blood macrophages of healthy adults. Cytometry A 2006. 69: 152–154.
32. Dehio, M., Knorre, A., Lanz, C. and Dehio, C., Construction of versatile high-level expression vectors for Bartonella henselae and the use of green fluorescent protein as a new expression marker. Gene 1998. 215: 223–229.
33. Cuenca, A. G., Cuenca, A. L., Gentile, L. F., Efron, P. A., Islam, S., Moldawer, L. L., Kays, D. W. et al., Delayed emergency myelopoiesis following polymicrobial sepsis in neonates. Innate Immun. 2015. 21:386–391.
34. Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V. et al., PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014. 211:781–790.